Last Updated: June 18, 2026

Suppliers and packagers for ALEVE


✉ Email this page to a colleague

« Back to Dashboard


ALEVE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bayer ALEVE naproxen sodium TABLET;ORAL 020204 NDA Bayer HealthCare LLC 0280-0041-01 1 BOTTLE in 1 CARTON (0280-0041-01) / 175 TABLET in 1 BOTTLE 2021-06-01
Bayer ALEVE naproxen sodium TABLET;ORAL 020204 NDA Bayer HealthCare LLC 0280-0041-02 1 BOTTLE in 1 CARTON (0280-0041-02) / 50 TABLET in 1 BOTTLE 2021-06-01
Bayer ALEVE naproxen sodium TABLET;ORAL 020204 NDA Bayer HealthCare LLC 0280-0041-03 1 BOTTLE in 1 CARTON (0280-0041-03) / 90 TABLET in 1 BOTTLE 2021-06-01
Bayer ALEVE naproxen sodium TABLET;ORAL 020204 NDA Bayer HealthCare LLC 0280-0041-04 1 BOTTLE in 1 CARTON (0280-0041-04) / 24 TABLET in 1 BOTTLE 2021-06-01
Bayer ALEVE naproxen sodium TABLET;ORAL 020204 NDA Bayer HealthCare LLC 0280-0041-05 1 TABLET in 1 POUCH (0280-0041-05) 2021-06-01
Bayer ALEVE naproxen sodium TABLET;ORAL 020204 NDA Bayer HealthCare LLC. 0280-0111-01 10 TABLET in 1 BOTTLE (0280-0111-01) 2023-04-04
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

ALEVE Suppliers: Active Ingredient, Dosage-Form Manufacturing, and Key Supply Chain Actors

Last updated: May 25, 2026

Aleve is the brand name for naproxen products sold in multiple strengths and dosage forms. The supplier picture is dominated by (1) naproxen API supply, (2) finished-dose manufacturers for oral tablets/caplets and liquid formulations, and (3) excipient and packaging suppliers tied to specific label/strengths.

Who supplies ALEVE (naproxen) API and finished-dose manufacturers?

What companies manufacture Aleve naproxen tablets and caplets

Aleve is sold in the US as prescription-free OTC naproxen products under Bayer’s brand. The US “manufacturer” shown on the OTC package is typically the finished-dose contract or affiliate producing the specific NDC/strength, even when Bayer is the marketing authorization holder.

Key manufacturing patterns in OTC NSAIDs generally include:

  • API suppliers that produce naproxen (and sometimes intermediate chemistry).
  • Finished-dose suppliers that compress/formulate tablets or caplets (often under contract).
  • Packaging and secondary packaging vendors tied to blister or bottle formats.

What companies supply naproxen API for Aleve

Naproxen API supply is usually concentrated among global generic API plants in India, China, and Europe. Contract API distribution flows through branded OTC supply chains, but the specific naproxen API manufacturer for a given Aleve NDC changes by lot and market.

No complete, NDC-level supplier list is available here to enumerate “the suppliers for Aleve” in a way that is accurate across all strengths and markets.

What are the key supplier categories for Aleve naproxen OTC products?

API manufacturing supply

Primary drivers for identifying “API suppliers”:

  • Naproxen chemical supply chain (API producer and/or API trader).
  • Regulatory DMF/CEP holder relationships tied to upstream API processes.
  • Lot traceability mechanisms used by OTC manufacturers.

Finished-dose manufacturing and formulation

Finished-dose suppliers typically cover:

  • Tablet/caplet compression and coating lines.
  • Blister/bottle packaging line integration.
  • Quality systems for OTC GMP compliance, including COA and stability commitments.

Excipients and packaging

For OTC NSAIDs, common excipient and packaging categories include:

  • Direct compression excipients and binders.
  • Film coating components for caplets.
  • Desiccant and induction seals where bottles are used.
  • Blister foils and lidding materials where blister SKUs exist.

Which suppliers make specific Aleve dosage forms (caplets, tablets, liquid gels)?

How are Aleve dose forms differentiated in sourcing

Aleve product codes differentiate supply contracts through:

  • NDC per strength and dosage form.
  • Lot-specific packaging formats (bottle vs blister).
  • Stabilizer/coating system differences between caplet/tablet lines.

Are the suppliers the same across strengths (220 mg, 250 mg, 375 mg, 500 mg, 550 mg, etc.)

Usually no:

  • Different strengths often use different tooling, coating weights, and packaging configurations.
  • Contract manufacturing locations can change for seasonal demand.

What is the supply-chain structure behind Bayer’s Aleve branding?

Marketing vs manufacturing roles

In OTC:

  • Bayer (or a Bayer subsidiary) typically owns brand and label.
  • A separate entity (affiliate or contract manufacturer) produces the finished dose.
  • Distribution and secondary packaging can be performed by logistics partners.

How to map “suppliers” to legal/label responsibility

Supplier identification in practice is done through:

  • OTC labeling “Manufactured for” / “Distributed by” statements.
  • NDC labeler codes tied to specific finished-dose firms.
  • FDA OTC drug facility registrations and inspection histories (when publicly reviewed).

What regulatory sources identify Aleve manufacturers and facilities?

How FDA data maps to suppliers

For finished-dose manufacturing:

  • Facility registration identifies plants producing drugs, including OTC.
  • Drug listing/NDC labeler can map to the firm responsible for the marketed package label.

For API:

  • DMF/CEP data can identify upstream API applicants, but it does not always map cleanly to the exact lot used for a given NDC without additional traceability.

Which suppliers are involved in manufacturing Aleve across geographies?

Common geography patterns

  • API: India/China/Europe plants dominate global naproxen supply for generic NSAID lines.
  • Finished dose: US and international contract manufacturing plants support shelf demand and packaging conversion.

Why supplier footprints differ by region

  • Regulatory registrations differ by country.
  • Local packaging formats and local excipient approvals drive plant selection.
  • Supply resilience strategies shift manufacturing sites year-to-year.

What is the competitive supply landscape for naproxen OTC (beyond Aleve)?

How Aleve sourcing compares with generic naproxen

Brand OTC supply chains often share the same API supplier universe as generics but differ in:

  • Finished-dose contract manufacturing selection.
  • Packaging conversion and label systems.
  • Stability and shelf-life commitments to meet OTC claims.

What that means for “suppliers” searches

If you search “Aleve suppliers” you usually land on:

  • Finished-dose manufacturers per NDC.
  • API supply firms that are not publicly tied to a specific Aleve NDC without label or regulatory crosswalk.

What patent or exclusivity status affects Aleve supply suppliers?

Aleve is an OTC naproxen brand. Naproxen is long off-patent, so supply constraints are primarily:

  • GMP capacity constraints.
  • Supply chain quality and regulatory compliance.
  • Packaging format capacity.

Patent estate does not typically block generic or contract manufacturing of naproxen OTC; supplier selection is execution and compliance-driven rather than IP-driven.


Key Takeaways

  • Aleve is naproxen-based and sold across multiple strengths and dosage forms, which means suppliers vary by NDC, strength, and packaging format.
  • “Suppliers for Aleve” is best interpreted as API suppliers (naproxen), finished-dose manufacturers, and packaging/excipient suppliers; these roles are often split across different firms and geographies.
  • A complete, accurate list of named suppliers cannot be produced from the information provided in this prompt without using NDC- and label-level sources.

FAQs

  1. How do I find the exact Aleve manufacturer for my specific NDC/strength?
  2. Are Aleve caplets and Aleve tablets made by the same contract manufacturer?
  3. Who supplies naproxen API for OTC brands like Aleve?
  4. Do FDA facility registrations show the actual Aleve contract manufacturing plant?
  5. What supply chain firms typically provide blister packaging for OTC NSAID caplets?

References

  1. FDA. Orange Book. https://www.accessdata.fda.gov/scripts/cder/daf/
  2. FDA. Drugs@FDA. https://www.accessdata.fda.gov/scripts/cder/daf/
  3. FDA. NDC Directory. https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
  4. FDA. Drug Facility Registration. https://www.fda.gov/drugs/drug-facility-registration-and-listing

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.